Procurement Opportunity: SPECTROPHOTOMETER

The eligibility requirements include being a registered entity, having a minimum of three years of relevant experience in supplying similar products, an average annual turnover of at least 2 lakh during the last three financial years, and OEM authorization documents.

Bidders must provide several certificates including an OEM authorization, past performance records, and evidence of bidder turnover. Additional documents might be requested based on the Acceptance Testing Criteria (ATC).

To register for this tender, a bidder needs to ensure compliance with tender requirements and then submit the necessary documentation as outlined in the bid document, including registration to the relevant government portals.

The preferred document formats typically include PDF and other commonly used formats except for any specific formats mentioned in the tender documentation. It is advised to check the requirements in the tender document.

The technical specifications for the spectrophotometer include operational accuracy, compliance with industrial standards, and specific capabilities that must meet the Department of Drugs Control requirements as mentioned in the documents.

Bidders must uphold quality standards that are aligned with governmental regulations and industry benchmarks specified in the tender documentation, ensuring that the supplied equipment meets required specifications.

Yes, bidders must comply with the procurement policies stated by the authority, including any necessary quality and safety certifications specifically mentioned in the tender details.

For this tender, the EMD requirement is indicated as not required. Bidders should refer to the tender documentation for any updates or changes to this requirement.

Yes, successful bidders are required to submit an ePBG with a percentage of 2.50% of the total bid amount, which must remain valid for a specified duration as outlined in the tender requirements.

Payment terms will be detailed further in the contract following the successful awarding of the bid, focusing on compliance with Department of Drugs Control’s procurement policies and standards.

The bids will be evaluated based on a total value-wise evaluation method, taking into account the overall cost, compliance with specifications, and the qualifications of the bidder as outlined in the tender document.

The notification of results will be conducted following the bid opening date and will include details sent to participating bidders according to the guidelines set forth by the Department of Drugs Control.

This tender does not provide benefits for MSEs, specifically regarding exemptions from experience and turnover requirements. Interested MSE bidders should review the full tender requirements for broader opportunities.

Similar to MSEs, there are no exemptions provided for startups concerning years of experience and turnover, as outlined in the tender details.

Bids should reflect adherence to 'Make in India' policies as part of the procurement approach, accentuating local manufacturing and sourcing where applicable.

The detailed local content requirements are included within the tender documentation for uniform compliance to support indigenous manufacturing efforts.

These FAQs aim to provide clarity on the expectations and requirements for all prospective bidders as they prepare submissions for the tender GEM/2024/B/5593643.